Showing results 21 to 40 of 55
< previous
next >
| Issue Date | Title | Author(s) |
| 2015-08-03 | Mono- and Cocultures of Bronchial and Alveolar Epithelial Cells Respond Differently to Proinflammatory Stimuli and Their Modulation by Salbutamol and Budesonide | Haghi, M; Hittinger, M; Zeng, Q; Oliver, B; Traini, D; Young, PM; Huwer, H; Schneider-Daum, N; Lehr, CM |
| 2015-07-03 | In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation | Trotta, V; Lee, WH; Loo, CY; Haghi, M; Young, PM; Scalia, S; Traini, D |
| 2015-06-01 | CURCUMIN AND SILVER NANOPARTICLE HYDROGELS FOR ENDOTRACHEAL TUBE-ASSOCIATED INFECTIONS: CHARACTERIZATION AND ANTI-BIOFILM ACTIVITIES | Loo, J; Lee, W-H; Young, PM; Traini, D; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R |
| 2015-06-01 | Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection | Arora, S; Haghi, M; Loo, CY; Traini, D; Young, PM; Jain, S |
| 2015-05-26 | Inhalable tranexamic acid for haemoptysis treatment | Haghi, M; Van Den Oetelaar, W; Moir, LM; Zhu, B; Phillips, G; Crapper, J; Young, PM; Traini, D |
| 2015-05-05 | The formulation of a pressurized metered dose inhaler containing theophylline for inhalation | Zhu, B; Haghi, M; Goud, M; Young, PM; Traini, D |
| 2015-04-07 | A 'soft spot' for drug transport: Modulation of cell stiffness using fatty acids and its impact on drug transport in lung model | Haghi, M; Traini, D; Wood, LG; Oliver, B; Young, PM; Chrzanowski, W |
| 2015-03-30 | Evolved gas analysis during thermal degradation of salbutamol sulphate | Sonvico, F; Coleman, V; Traini, D; Young, PM |
| 2015-01-01 | Implications and emerging control strategies for ventilator-associated infections | Loo, CY; Lee, WH; Young, PM; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R |
| 2014-08 | SYNTHESIS OF CURCUMIN NANOPARTICLES FOR LUNG CANCER THERAPY | Lee, W-H; Ong, H-X; Loo, C-Y; Traini, D; Young, PM; Luk, F; Bebawy, M; Rohanizadeh, R |
| 2014-08 | COMBINATION THERAPY OF CURCUMIN AND SILVER NANOPARTICLES WITH ENHANCED ANTI-BIOFILM ACTIVITY FOR TREATMENT OF ENDOTRACHEAL TUBE-ASSOCIATED INFECTIONS | Loo, C-Y; Young, PM; Lee, W-H; Traini, D; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R |
| 2014-01-01 | Non-cytotoxic silver nanoparticle-polyvinyl alcohol hydrogels with anti-biofilm activity: Designed as coatings for endotracheal tube materials | Loo, CY; Young, PM; Lee, WH; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R |
| 2014-01-01 | The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler | Saadat, A; Zhu, B; Haghi, M; King, G; Colombo, G; Young, PM; Traini, D |
| 2014-01-01 | Towards the bioequivalence of pressurised metered dose inhalers 1: Design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient | Lewis, DA; Young, PM; Buttini, F; Church, T; Colombo, P; Forbes, B; Haghi, M; Johnson, R; O'Shea, H; Salama, R; Traini, D |
| 2014-01-01 | Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro | Haghi, M; Bebawy, M; Colombo, P; Forbes, B; Lewis, DA; Salama, R; Traini, D; Young, PM |
| 2014-01-01 | Silver nanoparticles enhance Pseudomonas aeruginosa PAO1 biofilm detachment | Loo, CY; Young, PM; Cavaliere, R; Whitchurch, CB; Lee, WH; Rohanizadeh, R |
| 2014-01-01 | In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation | Ong, HX; Benaouda, F; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Forbes, B; Young, PM |
| 2014-01 | Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa | Pozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D |
| 2014 | Effect of Particle Size and Excipients on the Uptake of Beclomethasone Dipropionate-Pressurized Metered Dose Inhalers After Deposition on Calu-3 Respiratory Epithelia | Haghi, M; Traini, D; Lewis, DA; Forbes, B; Colombo, P; Young, PM; Dalby RN, Byron PR, Peart J, Suman JD, Young PM, Traini D |
| 2013-11-01 | Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler | Haghi, M; Traini, D; Postma, DS; Bebawy, M; Young, PM |
